Dendritic cells modified with 6Ckine/IFNγ fusion gene induce specific cytotoxic T lymphocytes in vitro
- First Online:
- Cite this article as:
- Xue, G., Liu, R., Li, Y. et al. Cancer Immunol Immunother (2007) 56: 1831. doi:10.1007/s00262-007-0327-y
- 83 Downloads
Backgroud and objective
Dendritic cells play an important role in initiation and regulation of immune responses. Previous studies demonstrated that intratumoral administration of 6Ckine-modified DCs enhanced local and systemic antitumor effects. Herein we report the investigation of the specific CTL responses elicited by adenoviral 6Ckine/IFNγ fusion gene-modified DCs in vitro.
Human monocyte-derived DCs were modified with an adenoviral vector encoding 6Ckine/IFNγ fusion protein (Ad-6Ckine/IFNγ), and then investigated the effect of 6Ckine/IFNγ fusion protein on the maturation, cytokine and chemokine secretion of DCs, and their activities of recruiting and activating T cells in vitro were investigated.
6Ckine/IFNγ fusion protein induced DC maturation characterized with the upregulation of CD83 and CCR7. And it up-regulated the expression of RANTES and IL-12p70, down-regulated that of IL-10 in DCs. Additionally, 6Ckine/IFNγ markedly increased DC’s recruiting ability for naive T cells, benefiting from the enhanced expression of chemokines 6Ckine and RANTES in DCs. Fusion gene-modified DCs significantly promoted the proliferation of autologous T cells, induced Th1 differentiation by upregulating the expression of IL-2 and T-bet in T cells, and increased specific cytotoxicity of CTLs against specific tumor cells, HepG2 or LoVo cells, respectively.
Combining the effects of 6Ckine and IFNγ, Ad-6Ckine/IFNγ modified DCs induced enhanced CTL responses in vitro, which indicated that Ad-6Ckine/IFNγ modified DCs might be used as an adjuvant to trigger an effective antitumor immune response.
KeywordsDendritic cells Cytokines Chemokines Tumor immunology Gene therapy
Recombinant adenovirus carrying 6Ckine/IFNγ fusion gene
Recombinant adenoviruses carrying 6Ckine gene
Recombinant adenoviruses carrying IFNγ gene
Recombinant adenoviruses carrying β-galactosidase gene
Recombinant adenoviruses carrying green fluorescent protein gene
DC transfected with Ad-6Ckine
DC transfected with Ad-6Ckine/IFNγ
DC transfected with Ad-IFNγ
DC transfected with Ad-LacZ
National Institute for the Control of Pharmaceutical and Biological Products